Edouard J. Louis

Edouard J. Louis

Liege, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 385 publications

Multi-level aggregation analysis of microbiome composition and host gene expression reveals associations with systemic and local immunity.

Multi-level aggregation analysis of microbiome composition and host gene expression reveals associations with systemic and local immunity.

Journal: Microbiology spectrum

Published: August 10, 2026

Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group.

Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group.

Journal: Journal of Crohn's & colitis

Published: August 09, 2026

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

Journal: medRxiv : the preprint server for health sciences

Published: May 25, 2026

Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 01, 2026

Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trial.

Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trial.

Journal: Nature communications

Published: January 29, 2026

Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.

Development and External Validation of a Predictive Model for Postoperative Recurrence of Crohn's Disease in the Biologic Era.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: January 24, 2026

Effects of prehabilitation programmes on postoperative outcomes in older adults undergoing major abdominal, cardiac or vascular surgery: a systematic review.

Effects of prehabilitation programmes on postoperative outcomes in older adults undergoing major abdominal, cardiac or vascular surgery: a systematic review.

Journal: Aging clinical and experimental research

Published: December 18, 2025

Cladribine monotherapy in a patient with coexisting Crohn's disease and multiple sclerosis.

Cladribine monotherapy in a patient with coexisting Crohn's disease and multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 01, 2025

QuantiFERON-Monitor as prognostic marker of mortality in patients with decompensated cirrhosis: A prospective cohort study.

QuantiFERON-Monitor as prognostic marker of mortality in patients with decompensated cirrhosis: A prospective cohort study.

Journal: Clinics and research in hepatology and gastroenterology

Published: September 28, 2025

Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study.

Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study.

Journal: The American journal of gastroenterology

Published: September 23, 2025

International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.

International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials.

Journal: Journal of Crohn's & colitis

Published: September 19, 2025

The Effect of Dose Intensification After Secondary Loss of Response to Ustekinumab in Crohn's Disease: Results of the REScUE Study.

The Effect of Dose Intensification After Secondary Loss of Response to Ustekinumab in Crohn's Disease: Results of the REScUE Study.

Journal: Gastroenterology

Published: September 13, 2025

Showing 1-12 of 385

Last Updated: 09/26/2026